𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The effect of NMDA receptor antagonists on the neuroleptics-induced catalepsy in mice

✍ Scribed by J. Maj; Z. Rogóż; G. Skuza; H. Sowińska


Publisher
John Wiley and Sons
Year
1993
Tongue
English
Weight
309 KB
Volume
8
Category
Article
ISSN
0885-6222

No coin nor oath required. For personal study only.

✦ Synopsis


Theeffect of non-competitive (MK-801: /+/-5-methyl-l0,1 I-dihydro-5H-dibenzo [a,d] cyclohepten-5.10-imine hydrogen maleate) and competitive (CGP 37849: DL-/E/-2-amino-4-methyl-5-phosphono-3-pentenoic acid) NMDA receptor antagonists on the catalepsy induced by neuroleptics in mice was studied. MK-801 and CGP 37849 antagonized the catalepsy induced by haloperidol, spiperone and fluphenazine. (+)-Cycloserine, a partial glycine agonist, reversed the anticataleptic effect of CGP 37849, but not that of MK-801. The above results indicate that the anticataleptic activity of both these NMDA receptor antagonists is induced by an indirect activation of the dopamine system. The results provide further evidence that competitive NMDA receptor antagonists may be a new class of antiparkinsonian drugs.


📜 SIMILAR VOLUMES


Effect of NMDA receptor antagonist on na
✍ Ahmad Reza Dehpour; Morteza Samini; Hossein Rastegar; Abazar Jamshidi Ardeshiri; 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB 👁 2 views

The ability of NMDA antagonist MK-801 to block the expression of opioid-like withdrawal signs was examined in bile duct-ligated mice and the signs were compared with sham operated and unoperated animals. Administration of MK-801 (0/1 mg/kg), 10 min prior to naloxone challenge, significantly reduced

Effects of NMDA receptor channel blockad
✍ Irina V. Belozertseva; Anton Y. Bespalov 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 285 KB 👁 2 views

N-Methyl-D-aspartate (NMDA) receptor antagonists are perspective candidates for medication development for a number of diseases/states that are associated with increased aggressiveness (e.g., opioid withdrawal). The prototypic NMDA receptor antagonist phencyclidine (PCP) itself is a widely abused su

Nitric oxide donor molsidomine attenuate
✍ Nikolaos Pitsikas; Styliani Zisopoulou; Nikolaos Sakellaridis 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB

There is experimental evidence indicating that the noncompetitive NMDA receptor antagonist MK-801 impairs cognition and produces a series of schizophrenia-like symptoms in rodents (hypermotility, stereotypies, and ataxia). The present study was designed to investigate the efficacy of the nitric oxid